Skip to main content
OpenTrials
Completed

NCT Number: NCT01996020

Measurement of Cerebral Flow Using Transfontanellar Doppler in Infants Under Cardiopulmonary Bypass

Transfontanellar Doppler can measure the velocity at both the carotid artery and the anterior cerebral artery during cardiopulmonary bypass in congenital heart disease patients. This study can provide reference value of appropriate cerebral blood flow velocity during pediatric cardiac surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 1 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Hospital

Seoul, 110-744, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • the patients less than 1 year of age undergo congenital heart surgery with cardiopulmonary bypass
  • written informed consent is obtained from their guardians in accordance with the requirements of the local ethics committee

Exclusion criteria

  • synostosis
  • skull abnormality or fracture
  • epidural hematoma, scalp hematoma

Treatment and study plan

Primary outcomes

  1. cerebral blood flow velocity

    Time frame: 6hour

    during cardiac surgery

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

Intraoperative Trans-fontanel Cerebral Ultrasonography in Infants During Pediatric Cardiac Surgery Under Cardiopulmonary Bypass

Important dates

Study start
2012
Primary completion
2013
Study completion
2014
First posted
Nov 27, 2013
Registry last updated
May 21, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.